METTL24: A Potential Drug Target and Biomarker (G728464)

Target Name: METTL24

NCBI ID: G728464

METTL24

METTL24: A Potential Drug Target and Biomarker

Methyltransferase-like protein 24 (METTL24) is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. METTL24 is a key player in the methylation machinery, which is responsible for the regulation of gene expression and DNA replication. METTL24 has been shown to play a crucial role in the regulation of cellular processes that are essential for human health and disease, including cell division, apoptosis, and inflammation.

The methylation machinery is a complex network of proteins that work together to ensure the accurate and precise regulation of gene expression. METTL24 is one of the key enzymes in this machinery, responsible for the transfer of methyl groups from the DNA to the histone proteins. This process is critical for the regulation of gene expression and the maintenance of cellular identity and stability. METTL24 has been shown to play a crucial role in the regulation of cellular processes that are essential for human health and disease, including cell division, apoptosis, and inflammation.

METTL24 has also been shown to be involved in the regulation of cellular signaling pathways that are involved in cancer, neurodegenerative disorders, and autoimmune diseases. For example, METTL24 has been shown to play a role in the regulation of the PI3K/Akt signaling pathway, which is involved in cell survival and proliferation. METTL24 has also been shown to be involved in the regulation of the NF-kappa-B signaling pathway, which is involved in inflammation and cellular stress.

In addition to its role in the regulation of cellular processes, METTL24 has also been shown to be involved in the regulation of cellular interactions with the environment. For example, METTL24 has been shown to play a role in the regulation of cellular responses to stress, such as nutrient deprivation and UV radiation. METTL24 has also been shown to play a role in the regulation of cellular interactions with the cell membrane, including the regulation of ion channels and the maintenance of cellular integrity.

METTL24 has also been shown to be involved in the regulation of cellular processes that are essential for normal development and growth. For example, METTL24 has been shown to play a role in the regulation of cell division and the maintenance of cellular identity and stability during development. METTL24 has also been shown to play a role in the regulation of cell growth and the maintenance of cellular mass during growth and development.

In conclusion, METTL24 is a protein that has been shown to play a crucial role in the regulation of various cellular processes that are essential for human health and disease. The methylation machinery is a complex network of proteins that work together to ensure the accurate and precise regulation of gene expression, and METTL24 is one of the key enzymes in this machinery. METTL24 has also been shown to be involved in the regulation of cellular signaling pathways that are involved in cancer, neurodegenerative disorders, and autoimmune diseases. As a potential drug target and biomarker, METTL24 is a promising target for the development of new treatments for these diseases.

Protein Name: Methyltransferase Like 24

Functions: Probable methyltransferase

The "METTL24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about METTL24 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets